Wells Fargo Upgrades United Therapeutics to Overweight, Raises Price Target to $738

Benzinga Newsdesk www.benzinga.com Positive 88.9%

Neg 0% Neu 0% Pos 88.9%

Wells Fargo analyst Benjamin Burnett upgrades United Therapeutics (NASDAQ:UTHR) from Equal-Weight to Overweight and raises the price target from $575 to $738.